STAAR Surgical
STAA
152 hedge funds and large institutions have $1.06B invested in STAAR Surgical in 2019 Q3 according to their latest regulatory filings, with 23 funds opening new positions, 44 increasing their positions, 61 reducing their positions, and 24 closing their positions.
297% more call options, than puts
Call options by funds: $21.2M | Put options by funds: $5.35M
20% more funds holding in top 10
Funds holding in top 10: 5 → 6 (+1)
1.47% more ownership
Funds ownership: 91.04% → 92.51% (+1.5%)
4% less first-time investments, than exits
New positions opened: 23 | Existing positions closed: 24
2% less funds holding
Funds holding: 155 → 152 (-3)
11% less capital invested
Capital invested by funds: $1.19B → $1.06B (-$128M)
28% less repeat investments, than reductions
Existing positions increased: 44 | Existing positions reduced: 61
Top Buyers
Top Sellers
| 1 |
DM
Deerfield Management
New York
|
-$25.8M |
| 2 |
AQR Capital Management
Greenwich,
Connecticut
|
-$11.6M |
| 3 |
PAI
Palo Alto Investors
Palo Alto,
California
|
-$10.5M |
| 4 |
Renaissance Technologies
New York
|
-$5.63M |
| 5 |
N
Nuveen
Charlotte,
North Carolina
|
-$5.5M |
STAA Hedge Fund Activity: Q3 2019 in Review
152 of the 4,560 institutional investors tracked by Wall St. Rank reported a position in STAAR Surgical (STAA) for Q3 2019, worth a combined $1.06B — down 11% from $1.19B a quarter earlier.
Sellers outnumbered buyers: 24 funds closed out of STAA and 23 opened new positions — a net loss of 1 holder — while 61 trimmed existing stakes and 44 added.
The largest buyer was Capital International Investors, adding an estimated $27.7M. The largest seller was Deerfield Management, exiting entirely with an estimated $25.8M sold.
- 152 institutional investors held STAAR Surgical (STAA) as of Q3 2019, down from 155 in Q2 2019.
- Funds reported $1.06B of STAAR Surgical stock for Q3 2019, down 11% quarter-over-quarter.
- 23 funds opened new STAAR Surgical positions in Q3 2019 and 24 closed out, a net change of -1 holder.
- The largest STAAR Surgical buyer in Q3 2019 was Capital International Investors, an estimated $27.7M added.
- The largest STAAR Surgical seller in Q3 2019 was Deerfield Management, an estimated $25.8M sold.
Based on aggregated 13F filings for Q3 2019.